367 / 1631
What About PET-adapted Selection of Patients for RT?
GHSG HD15
• “The results from HD15 study also support a reduced
role for radiation therapy in frontline therapy for
advanced Hodgkin lymphoma…demonstrating that
radiation therapy can be omitted in cases that have
residual disease on CT imaging following BEACOPP-
based chemotherapy but are FDG-PET-negative”
• “…..these results support the omission of
radiotherapy in advanced-stage HL patients who
achieve a PET-negative remission after 6 cycles of
chemotherapy.”